• WHX Labs Dubai will be held concurrently with World Health Dubai (WHX) from February 10-13 at the Dubai World Trade Centre, forming the largest global event in the healthcare sector .
• Leading global laboratory companies such as Sysmex, Snip, and Beckman Coulter are preparing to showcase their latest solutions at WHX Labs in Dubai.

Dubai, UAE: WHX Labs Dubai, formerly known as Medlab Middle East, the region’s leading event for medical laboratories and in vitro diagnostics, will celebrate 25 years of innovation at its next edition, which will take place from February 10-13, 2026 at the Dubai World Trade Centre.

WHX Labs Dubai will provide an ideal platform for deal-making, networking, and knowledge sharing, while addressing some of the most pressing challenges in medical laboratory science. The event is held under the patronage of the UAE Ministry of Health and Prevention, reinforcing the country’s commitment to providing world-class healthcare.

Celebrating a quarter-century of success, WHX Labs Dubai will be held under the theme "25 Years of Laboratory Innovation: Uniting Communities for Better Health," and will present an international exhibition of excellence in medical laboratories, diagnostics and precision medicine.

In 2025, WHX Labs Dubai generated US$621 million in business and attracted 27,853 trade visitors. The 2026 edition of the event is set to host more than 800 exhibitors from over 40 countries and is expected to welcome more than 35,000 trade visitors.

On this occasion, Tom Coleman, Group Exhibition Director at Informa Markets Healthcare, said: “With its leadership in the laboratory sector in the UAE for 25 years, WHX Labs Dubai continues to lead the future of healthcare. Over four days, the 2026 edition of the exhibition will bring together a select group of leading laboratory experts, healthcare pioneers, innovators and technology providers from around the world at the Dubai World Trade Centre, providing new possibilities in the field of global healthcare diagnostics.”

The next edition of the event will see the launch of two major new conferences, the Global Precision Health Forum and the Antimicrobial Resistance Leaders Summit, further enhancing the event’s role as a global platform to promote innovation and collaboration in healthcare.

The Global Precision Health Forum will be held on February 10 and 11, bringing together leading global experts to explore the promising prospects of genomics and precision health. The inaugural edition of the forum aims to foster connections between scientists, innovators, healthcare leaders and policymakers to lay the initial foundations for a shared future of precision health.

With a focus on regional priorities and international best practices, the forum will highlight how cross-border collaboration can contribute to opening up new opportunities in research, innovation and equity in health.

Chaired by Dr. Amira Alsheheeb Aqeel, Director of the Metabolic and Mendelian Disorders Research Program and Principal Investigator at Sidra Medicine, Qatar, the forum will explore how to apply genomic discoveries in clinical settings, leverage data and artificial intelligence in precision health, and overcome challenges to deliver personalized treatments, among other key areas.

In response to the growing global threat of antimicrobial resistance, the Antimicrobial Resistance Leaders Summit will be held on February 12 and 13, bringing together a multidisciplinary alliance of scientists, clinicians, policymakers and innovators to bridge the gap between research and application. The summit, chaired by Dr. Wael Al-Amin, Medical Director of Environmental Sciences at M42 , aims to stimulate practical dialogue and collaborative solutions.

The Antimicrobial Resistance Conference will also bring together a multidisciplinary audience from academia, clinical practice, health policy, diagnostics experts, and representatives from the pharmaceutical industry. The program will include a variety of interactive formats designed to stimulate revolutionary industry discussions, including breakout sessions, debates, and panel discussions addressing specific cases.

The 25th Annual Conference on Laboratory Management and Medicine represents a significant achievement, as it will include eight accredited continuing medical education tracks, including laboratory management, hematology, clinical chemistry, clinical microbiology, molecular diagnostics, histopathology, laboratory quality management, transfusion medicine, and cell therapy.

Led by 250 global thought leaders and laboratory specialists, the conference will reflect on the 25-year journey of WHX Labs Dubai, under the theme "Celebrating the past and enabling the future of laboratory quality through innovation and global standards."

Participants at WHX Labs Dubai will have the opportunity to take part in interactive workshops led by industry experts from MGI Tech , Sysmex and Snibe , providing in-depth insights and networking opportunities.

WHX Labs Dubai will showcase the latest developments in eight specialized laboratory sectors, including: consumables, diagnostic testing, imaging and diagnostics, laboratory instruments, healthcare and public services, laboratory equipment, and laboratory instruments, reagents and chemicals.

The list of international healthcare leaders who have confirmed their participation in the event includes: Abbott, Al Borg Diagnostics , Beckman Coulter, Biomerier, Daedalus, PureLab, Randox, Sansure, Siemens Healthineers, Snipe Diagnostics, Sysmex Middle East, World Data Exchange, and others .

WHX Labs Dubai will be held concurrently with World Health Dubai (WHX), which will take place from February 9 to 12 at the Dubai Exhibition Centre.

About WHX Labs Dubai:

WHX Labs Dubai, formerly known as Medlab Middle East, is a leading global platform for laboratory and diagnostic innovation.

This event is part of the World Health Show (WHX), which brings together Informa's healthcare events around the world to facilitate networking and collaboration under one brand.

WHX Labs Dubai will complement MedLab Middle East’s 24-year success story, connecting more than half a million healthcare professionals in nine countries across four continents, thus integrating every event into Informa Markets’ healthcare portfolio.

Media contact:

Acid Calo

Public Relations Manager

Indigo Icon Tower – Jumeirah Lakes Towers

Dubai – United Arab Emirates

Office phone number: +971 4 3652711

Mobile phone: +971 55 822 5770

Email: osaid.kalo@shamalcomms.com

Website: www.shamalcomms.com

-I finish-

#Company Data

Disclaimer regarding the content of press releases
The content of this press release is provided by a third-party provider. We do not assume any responsibility for, nor do we have any control over, such content. This content is provided on an "as is" and "as available" basis and is not edited in any way. Neither we, nor our affiliates, will be liable for the accuracy, endorsement, or completeness of any opinions, views, information, or materials contained in this content.
This press release is provided for informational purposes only; the content does not constitute legal, investment, or tax advice, nor does it offer any opinion on the suitability, value, or profitability of any particular portfolio or investment strategy. Neither we nor our affiliates will be liable for any errors or inaccuracies in the content, or for any actions you take based on that content. You expressly agree and acknowledge full responsibility for your use of the information contained in this press release.
To the extent permitted by applicable law, Refinitiv, its parent company, subsidiaries, affiliates, relevant shareholders, directors, officers, employees, agents, advertisers, content providers, and licensors (collectively, the 'Refinitiv Parties') shall not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive, or exemplary damages; This includes, but is not limited to, losses of profits, savings, or revenues, whether due to negligence, tort, contract, or other theories of liability, even if the parties to Refinitiv were advised of the possibility of any such damages or losses occurring or actually anticipated them.